Magnetic Resonance Imaging of Therapy-Induced Necrosis Using Gadolinium-Chelated Polyglutamic Acids
- 22 March 2007
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 68 (3) , 830-838
- https://doi.org/10.1016/j.ijrobp.2007.01.011
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- 643 POSTER Energy dependent uptake of paclitaxel poliglumex by human NSCLC tumor and murine macrophage-like cell linesEuropean Journal of Cancer Supplements, 2006
- 637 POSTER Paclitaxel poliglumex cellular uptake by normal tissues and human tumor xenograft: an IHC study in nude miceEuropean Journal of Cancer Supplements, 2006
- Significance of Histological Response to Preoperative Chemoradiotherapy for Pancreatic CancerAnnals of Surgical Oncology, 2005
- Synthesis and Characterization of Poly(l-glutamic acid) Gadolinium Chelate: A New Biodegradable MRI Contrast AgentBioconjugate Chemistry, 2004
- Correlations between Magnetic Resonance Spectroscopy and Image-guided Histopathology, with Special Attention to Radiation NecrosisNeurosurgery, 2002
- Correlations between Magnetic Resonance Spectroscopy and Image-guided Histopathology, with Special Attention to Radiation NecrosisNeurosurgery, 2002
- Poly(l-glutamic acid)–anticancer drug conjugatesAdvanced Drug Delivery Reviews, 2002
- Diffusion MRI for prediction of response of rectal cancer to chemoradiationPublished by Elsevier ,2002
- Potentiation of radioresponse by polymer–drug conjugatesJournal of Controlled Release, 2001
- Gadolinium-containing copolymeric chelates—a new potential MR contrast agentMagnetic Resonance Materials in Physics, Biology and Medicine, 1999